Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
66.32
+1.13 (1.73%)
Jul 9, 2025, 9:32 AM - Market open

PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Illumina stock at 5.81%, Alnylam Pharmaceuticals at 5.44%, Royalty Pharma at 5.29%, Amgen at 5.08%, and Vertex Pharmaceuticals at 4.90%.

Total Holdings
33
Top 10 Percentage
47.68%
Asset Class
Equity
ETF Category
Health
Assets
228.63M
PE Ratio
20.44

Sector Allocation

Top 25 Holdings

Jul 3, 2025
No.SymbolName WeightShares
1ILMNIllumina, Inc.5.81%131,912
2ALNYAlnylam Pharmaceuticals, Inc.5.44%37,509
3RPRXRoyalty Pharma plc5.29%332,867
4AMGNAmgen Inc.5.08%38,939
5VRTXVertex Pharmaceuticals Incorporated4.90%24,398
6GILDGilead Sciences, Inc.4.87%99,747
7BMRNBioMarin Pharmaceutical Inc.4.71%187,256
8UTHRUnited Therapeutics Corporation4.45%34,562
9AVXLAnavex Life Sciences Corp.3.80%805,337
10BPMCBlueprint Medicines Corporation3.33%59,318
11QGENQiagen N.V.2.86%135,355
12PTGXProtagonist Therapeutics, Inc.2.85%127,834
13ARWRArrowhead Pharmaceuticals, Inc.2.83%386,163
14CDNACareDx, Inc2.83%336,661
15EXELExelixis, Inc.2.78%137,743
16NBIXNeurocrine Biosciences, Inc.2.73%48,396
17DVAXDynavax Technologies Corporation2.72%606,885
18INCYIncyte Corporation2.72%90,824
19TGTXTG Therapeutics, Inc.2.70%168,426
20RGENRepligen Corporation2.70%48,436
21COLLCollegium Pharmaceutical, Inc.2.67%201,334
22PTCTPTC Therapeutics, Inc.2.66%124,015
23HALOHalozyme Therapeutics, Inc.2.57%109,066
24VCYTVeracyte, Inc.2.55%212,203
25FOLDAmicus Therapeutics, Inc.2.54%951,175
As of Jul 3, 2025
Showing 25 of 33
Subscribe to see the full list